Scancell Holdings plc is a biopharmaceutical company focused on the cancer therapeutics market. The Company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer. The Company is developing a pipeline of immunotherapies for the treatment of cancer based on its ImmunoBody and Moditope platforms. The Company's products include SCIB1, SCIB2 and Modi-1. The Company's first cancer vaccine, SCIB1, is being developed for the treatment of melanoma and is in Phase I/II clinical trials. SCIB2 contains multiple T cell epitopes derived from the lung cancer associated antigen NY-ESO-1. It is developed to the point at which the product is defined and ready for further preclinical development as an immunotherapy for any tumor that expresses the NY-ESO-1 antigen. The Company's first Moditope development candidate is Modi-1. Modi-1 consists of two citrullinated vimentin peptides and one citrullinated enolase peptide.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:SCLP
- CUSIP: N/A
- Web: N/A
- Market Cap: £28.12 million
- Outstanding Shares: 261,558,000
- 50 Day Moving Avg: GBX 12.63
- 200 Day Moving Avg: GBX 14.17
- 52 Week Range: GBX 9.68 - GBX 21.36
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.0000
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: GBX 0.03 per share
- Price / Book: 3.58
- Average Volume: 179,290 shs.
Frequently Asked Questions for Scancell Holdings Plc (LON:SCLP)
What is Scancell Holdings Plc's stock symbol?
Scancell Holdings Plc trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."
Where is Scancell Holdings Plc's stock going? Where will Scancell Holdings Plc's stock price be in 2017?
1 brokers have issued 1 year price objectives for Scancell Holdings Plc's shares. Their predictions range from GBX 68 to GBX 68. On average, they anticipate Scancell Holdings Plc's share price to reach GBX 68 in the next twelve months. View Analyst Ratings for Scancell Holdings Plc.
Who are some of Scancell Holdings Plc's key competitors?
Some companies that are related to Scancell Holdings Plc include K3 Business Technology Group plc (KBT), Revolution Bars Group PLC (RBG), Harvey Nash Group plc (HVN), Eagle Eye Solutions Group PLC (EYE), Zambeef Products Plc (ZAM), Begbies Traynor Group plc (BEG), GLI Finance Ltd (GLIF), Churchill Mining Plc (CHL), Castleton Technology PLC (CTP), Midatech Pharma PLC (MTPH), Quarto Group (QRT), Jubilee Platinum PLC (JLP), Caledonia Mining Corporation Plc Com (CMCL), Monitise Plc (MONI), Stadium Group plc (SDM), Amryt Pharma PLC (AMYT), Lombard Risk Management plc (LRM) and Frenkel Topping Group Plc (FEN).
How do I buy Scancell Holdings Plc stock?
Shares of Scancell Holdings Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Scancell Holdings Plc stock cost?
One share of Scancell Holdings Plc stock can currently be purchased for approximately GBX 10.75.
Consensus Ratings for Scancell Holdings Plc (LON:SCLP) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 68|
Analysts' Ratings History for Scancell Holdings Plc (LON:SCLP)
(Data available from 5/23/2015 forward)
|4/20/2017||Panmure Gordon||Reiterated Rating||Buy||GBX 68|
Earnings History for Scancell Holdings Plc (LON:SCLP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Scancell Holdings Plc (LON:SCLP)
Current Year EPS Consensus Estimate: $-1.20 EPS
Dividend History for Scancell Holdings Plc (LON:SCLP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Scancell Holdings Plc (LON:SCLP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Scancell Holdings Plc (LON:SCLP)
Latest Headlines for Scancell Holdings Plc (LON:SCLP)
Scancell Holdings Plc (SCLP) Chart for Tuesday, May, 23, 2017